« Back to Record
Spira, A., Awada, A., Isambert, N., Lorente, D., Penel, N., Zhang, H.-Y., Ojalvo, L., Hicking, C., Rolfe, A. P., Ihling, C., Dussault, I., Locke, G., & Borel, C. (2022). Identification of HMGA2 as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer. Frontiers in oncology, 12, 981940. doi:10.3389/fonc.2022.981940
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371136



